The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled
Year: 2019
Type: article
Abstract: The U.S. Drug Induced Liver Injury Network assayed the contents of herbal and dietary supplements collected from patients enrolled into its prospective study. The aim was to determine the accuracy of product labels, and to identify known hepatotoxins. Using high-performance liquid chromatography coupled with mass spectrometry to assay 272 product, 51% were found to be mislabeled; that is, to have chemical contents that did not match the label. Appearance enhancement, sexual performance, and weight loss products were most commonly mislabeled. Whether the mislabeling contributed to liver injury is under study; however, the high mislabeling rate underscores the need for more stringent regulation of supplements.
Source: Hepatology Communications
DOI: 10.1002/hep4.1346
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Awards: G1436523081, IU Clinical Center: Drug Induced Liver Injury Network, G151959291, Coordinating Center for the Drug Induced Liver Injury Network (DILIN), G38283659, Mount Sinai Regional Drug Induced Liver Injury Network Site, G7509555212, Michigan Hepatotoxicity Clinical Research Network Renewal, G884701208, Herbal and Dietary Supplement Induced Liver Injury in the U.S., University of North Carolina Clinical Center for DILIN, USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center
OpenAlex ID: W2926569512
